IL-22 increases S100A7, S100A8 and S100A9 gene expression, thus inhibiting epidermal differentiation by enhancing IL-6 secretion, and exerts a proinflammatory effect in AD lesions [114,121]. Here, IL22 is linked to Alzheimer disease.